Marker Therapeutics (MRKR) Earnings Analysis
Marker Therapeutics (MRKR) next reports earnings on 2026-08-13, consensus EPS -0.25 USD. Last quarter (2026-05-15) it beat with EPS -0.16 USD vs -0.18 USD est (+11.1%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E -1.85.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MRKR next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.25 USD |
| Revenue estimate | 0.00B |
MRKR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.16 USD | -0.18 USD | +11.1% | Beat |
| 2026-03-18 | -0.04 USD | -0.21 USD | +81% | Beat |
| 2025-11-13 | -0.12 USD | -0.36 USD | +66.7% | Beat |
| 2025-08-14 | -0.29 USD | -0.30385 USD | +4.6% | Beat |
| 2025-05-21 | -0.27 USD | -0.66 USD | +59.1% | Beat |
| 2025-03-31 | -0.42 USD | -0.22 USD | -90.9% | Miss |
| 2024-11-14 | -0.26 USD | -0.39 USD | +33.3% | Beat |
| 2024-08-14 | -0.29 USD | -0.43 USD | +32.6% | Beat |
Beat rate: 7/8 (88%) over reported quarters with consensus data.
MRKR valuation and analyst view
| Trailing P/E | -1.85 |
|---|---|
| Trailing EPS | -0.56417 USD |
| Price / book | 1.74 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (3 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Marker Therapeutics (MRKR)'s next earnings date?
Marker Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.25 USD and revenue estimate of 0.00B.
Did MRKR beat earnings last quarter?
In its 2026-05-15 report, MRKR posted EPS of -0.16 USD versus a -0.18 USD estimate — a beat of 11.1%.
What is MRKR's earnings track record?
Over the last 8 reported quarters with consensus data, MRKR beat estimates 7 times (88%).
What is MRKR's current P/E ratio and EPS?
MRKR trades at a trailing P/E of -1.85 on trailing EPS of -0.5641656512937113 USD.
What do analysts rate MRKR?
Analyst consensus is "Buy" across 5 ratings (1 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell).